ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway
10.1586/era.12.17
Saved in:
| Main Authors: | , , , |
|---|---|
| Other Authors: | |
| Format: | Review |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://scholarbank.nus.edu.sg/handle/10635/116889 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-116889 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1168892024-11-15T08:49:52Z ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway Ou, S.-H.I. Tan, J. Yen, Y. Soo, R.A. CANCER SCIENCE INSTITUTE OF SINGAPORE ALK inhibitor CD74-ROS1 cholangiocarcinoma crizotinib driver mutation FIG-ROS1 glioblastoma multiforme non-small-cell lung cancer personalized medicine ROS1 inhibitor ROS1 receptor tyrosine kinase SLC34A2-ROS1 10.1586/era.12.17 Expert Review of Anticancer Therapy 12 4 447-456 ERATB 2014-12-12T07:55:21Z 2014-12-12T07:55:21Z 2012-04 Review Ou, S.-H.I., Tan, J., Yen, Y., Soo, R.A. (2012-04). ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway. Expert Review of Anticancer Therapy 12 (4) : 447-456. ScholarBank@NUS Repository. https://doi.org/10.1586/era.12.17 14737140 http://scholarbank.nus.edu.sg/handle/10635/116889 000303228800010 Scopus |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
ALK inhibitor CD74-ROS1 cholangiocarcinoma crizotinib driver mutation FIG-ROS1 glioblastoma multiforme non-small-cell lung cancer personalized medicine ROS1 inhibitor ROS1 receptor tyrosine kinase SLC34A2-ROS1 |
| spellingShingle |
ALK inhibitor CD74-ROS1 cholangiocarcinoma crizotinib driver mutation FIG-ROS1 glioblastoma multiforme non-small-cell lung cancer personalized medicine ROS1 inhibitor ROS1 receptor tyrosine kinase SLC34A2-ROS1 Ou, S.-H.I. Tan, J. Yen, Y. Soo, R.A. ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway |
| description |
10.1586/era.12.17 |
| author2 |
CANCER SCIENCE INSTITUTE OF SINGAPORE |
| author_facet |
CANCER SCIENCE INSTITUTE OF SINGAPORE Ou, S.-H.I. Tan, J. Yen, Y. Soo, R.A. |
| format |
Review |
| author |
Ou, S.-H.I. Tan, J. Yen, Y. Soo, R.A. |
| author_sort |
Ou, S.-H.I. |
| title |
ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway |
| title_short |
ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway |
| title_full |
ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway |
| title_fullStr |
ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway |
| title_full_unstemmed |
ROS1 as a 'druggable' receptor tyrosine kinase: Lessons learned from inhibiting the ALK pathway |
| title_sort |
ros1 as a 'druggable' receptor tyrosine kinase: lessons learned from inhibiting the alk pathway |
| publishDate |
2014 |
| url |
http://scholarbank.nus.edu.sg/handle/10635/116889 |
| _version_ |
1821197072327507968 |